Skip to main content
SpringerLink
Log in

Movement Abnormalities: A Putative Biomarker of Risk for Psychosis

  • Chapter
The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes

Abstract

The link between movement abnormalities and psychotic disorders is presumed to reflect common neural mechanisms that influence both motor functions and vulnerability to psychosis. The high-risk or prodromal period preceding psychotic disorders represents both a viable point for intervention and a developmental period with high potential to shed light on etiology. In this chapter, we provide a background for understanding subtypes of movement abnormalities and underlying neurological mechanisms within the context of a neurodevelopmental conceptualization of psychosis and schizophrenia. We use these sections to provide a framework for reviewing and integrating studies of movement abnormalities in high-risk populations. These data are then evaluated to determine the viability of movement abnormalities as a biomarker. Potential directions for movement and biomarker research are evaluated and discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Puri BK, Barnes TR, Chapman MJ, Hutton SB, Joyce EM. Spontaneous dyskinesia in first episode schizophrenia. J Neurol Neurosurg Psychiatry 1999;66(1):76–78.

    Article  PubMed  CAS  Google Scholar 

  2. Khot V, Wyatt RJ. Not all that moves is tardive dyskinesia. Am J Psychiatry, 1991;148:661–666.

    PubMed  CAS  Google Scholar 

  3. Yarden PE, Discipio W. Abnormal movements and prognosis in schizophrenia. Am J Psychiatry, 1971;128:317–323.

    PubMed  CAS  Google Scholar 

  4. Walker EF. Developmentally Moderated Expressions of the Neuropathology Underlying Schizophrenia. Schizophr Bull 1994;20:453–480.

    PubMed  CAS  Google Scholar 

  5. Weinberger D. Implications of normal brain development for pathogenesis of schizophrenia. Arch Gen Psychiatry 1987;44:660–669.

    PubMed  CAS  Google Scholar 

  6. Fish B, Marcus J, Hans SL, Auerbach JG, Purdue S. Infants at risk for schizophrenia: Sequelae of a genetic neurointegrative defect. Arch Gen Psychiatry 1992;49:221–235.

    PubMed  CAS  Google Scholar 

  7. Fenton WS, Wyatt RJ, McGlashan TH. Risk factors for spontaneous dyskinesia in schizophrenia. Arch Gen Psychiatry 1994;51(8):643–50.

    PubMed  CAS  Google Scholar 

  8. Mittal VA, Neumann C, Saczawa M, Walker EF. The longitudinal progression of movement abnormalities and psychotic symptoms in adolescents at high-risk for psychosis. Arch Gen Psychiatry 2008;65(2):165–170.

    Article  PubMed  Google Scholar 

  9. Mittal VA, Walker EF. Movement abnormalities predict conversion to Axis I psychosis among prodromal adolescents. J Abn Psychol 2007;116(4):796–803.

    Article  Google Scholar 

  10. Mittal VA, Tessner KD, Trottman HD, Dhruv S, Esterberg M, Simeonova D, McMillan AL, Murphy E, Saczawa M, Walker EF. Movement abnormalities and the progression of prodromal symptomatology in adolescents at risk for psychotic disorders. J Abn Psychol 2007;116(2):260–267.

    Article  Google Scholar 

  11. Mittal VA, Dhruv S, Tessner KD, Walder DJ, Walker EF. The relations among putative bio risk markers in schizotypal adolescents: minor physical anomalies, movement abnormalities and salivary cortisol. Biol Psychiatry 2007;61(10):1179–1186.

    Article  PubMed  CAS  Google Scholar 

  12. Cassady SL, Adami H, Moran M, Kunkel R, Thaker GK. Spontaneous dyskinesia in subjects with schizophrenia spectrum personality. Am J Psychiatry 1998;155(1):70–5.

    PubMed  CAS  Google Scholar 

  13. Graybiel AM. The basal ganglia and cognitive pattern generators. Schizophr Bull 1997;23(3):459–469.

    PubMed  CAS  Google Scholar 

  14. Cannon TD, Cadenhead K, Cornblatt B et al., Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry 2008;65(1):28–37.

    Article  PubMed  Google Scholar 

  15. Klosterkotter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F: Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001;58:158–164.

    Article  PubMed  CAS  Google Scholar 

  16. Yung AR, McGorry PD. The initial prodrome in psychosis: Descriptive and qualitative aspects. Aust NZ J Psychiatry 1996;30:587–599.

    Article  CAS  Google Scholar 

  17. Haroun N, Dunn L, Haroun A, Cadenhead KS. Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophrenia Bull 2006;32(1):166–178.

    Article  Google Scholar 

  18. Falloon IRH. Early detection and intervention through integration with primary health services: The Buckingham Project. In: Miller T, Mednick SA, McGlashan TH, Libiger J, Johannessen JO, (Eds.), Early Intervention in Psychotic Disorders. Dordrecht, The Netherlands: Kluwer; 2001;123–133.

    Google Scholar 

  19. Preda A, Miller TJ, Rosen JL, Somjee L, McGlashan TH, Woods SW. Treatment histories of patients with a syndrome putatively prodromal to schizophrenia. Psychiatr Serv 2002;53:342–344.

    Article  PubMed  Google Scholar 

  20. Yung AR, Phillips LJ, McGorry PD, Hallgren MA, McFarlane CA, Jackson HJ, Francey S, Patton GC. Can we predict the onset of first-episode psychosis in a high-risk group? Int Clin Psychopharm 1998;13(Suppl 1):S23–S30.

    Google Scholar 

  21. Yung AR, McGorry PD. The initial prodrome in psychosis: descriptive and qualitative aspects. Aust New Zealand J Psychiatry 1996;30:587–599.

    Article  CAS  Google Scholar 

  22. Delong MR, Wichman T. Circuits and circuit disorders of the basal ganglia. Arch Neurol 2007;64(1):20–24.

    Article  PubMed  Google Scholar 

  23. Smith Y, Bevan MD, Shink E, Bolam P. Microcicuitry of the direct and indirect pathways of the basal ganglia. Neurosci 1998;86:353–387.

    Article  CAS  Google Scholar 

  24. Alexander GE, Crutcher MD, DeLong MR. Basal ganglia -thalamocortical circuits: Parallel substrates for motor, oculomotor, “prefrontal” and “limbic” functions. Prog Brain Res 1990;85:119–145.

    Article  PubMed  CAS  Google Scholar 

  25. Walker EF, Mittal VA, Tessner KD. HPA activity and the developmental course of schizophrenia. Annual Rev Clin Psychol 2008;4:5.1–5.28.

    Google Scholar 

  26. Corcoran C, Walker EF, Huot R, Mittal VA, Tessner K, Kestler K, Malaspina D. The stress cascade and schizophrenia: etiology and onset. Schizophr Bull 2003;29(4): 671–692.

    PubMed  Google Scholar 

  27. Walker EF, Diforio D. Schizophrenia: A neural diathesis-stress model. Psychol Rev 1997;104:667–685.

    Article  PubMed  CAS  Google Scholar 

  28. Erlenmeyer-Kimling L, Rock E, Roberts SA, Janal M, Kestenbaum C, Cornblatt B, et al. Attention, memory, and motor skills as childhood predictors of schizophrenia related psychoses: the New York Hih-Risk Project. Am J Psychiatry 2000;157(9):1416–1422.

    Article  PubMed  CAS  Google Scholar 

  29. Walker E., Lewis N, Loewy R., Palyo S. Motor dysfunction and risk for schizophrenia. Dev Psychopathol 1999;11: 509–523.

    Article  PubMed  CAS  Google Scholar 

  30. Rosso IM, Bearden CE, Hollister M, Gasperoni TM, Sanchez LE, Hadley T, et al. Childhood neuromotor dysfunction in schizophrenia patients and their unaffected siblings: a perspective cohort study. Schizophr Bull 2000;26(2): 367–378.

    PubMed  CAS  Google Scholar 

  31. Reiter PJ. Extrapyramidal motor-disturbances in dementia praecox. Acta Psychiatr Neurol Scand 1926;1:287–309.

    Article  Google Scholar 

  32. Honer WG, Kopala LC, Rabinowitz J. Extrapyramidal symptoms and signs in first episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness. Psychopharmacol 2005;18:277–228.

    Google Scholar 

  33. Mehler-Wex C, Riederer P, Gerlach M. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder. Neurotoxicity Res 2006;10(3–4):167–179.

    CAS  Google Scholar 

  34. Hoff JI, van den Plas AA, Wagemans EA, van Hilten JJ. Accelerometric assessment of levodopa-induced dyskinesias in Parkinson's disease. Mov Dis 2001;16(1):58–61.

    Article  CAS  Google Scholar 

  35. Gerlach J. Pathophysiological mechanisms underlying tardive dyskinesia. Psychopharmacol Suppl 1985;2:98–103.

    CAS  Google Scholar 

  36. Woods BT, Kinnery DK, Yurgelun-Todd D. Neurological abnormalities in schizophrenic patients and their families: I. Comparison of schizophrenic, bipolar, and substance abuse controls. Arch Gen Psychiatry 1986;43:657–663.

    PubMed  CAS  Google Scholar 

  37. Boks M. P., Liddle P. F., Burgerhof J. G., Knegtering, R. van den Bosch R. J. Neurological soft signs discriminating mood disorders from first episode schizophrenia. Act Psych Scand 2004;110(1):29–35.

    Article  CAS  Google Scholar 

  38. Neumann, CS, Walker EF. Childhood neuromotor softsigns, behavior problems and adult psychopathology. In: Ollendick T, Prinz R (Eds.), Advances in Clinical Child Psychology. New York: Plenum Press, 1996.

    Google Scholar 

  39. Roitberg BZ, Emborg ME, Sramek JG, Palfi S, Kordower JH. Behavioral and morphological comparison of two non-human primate models of Huntington's disease. Neurosurgery 2002:50(1);137–145.

    Article  PubMed  Google Scholar 

  40. Stahl SM, Davis KL, Berger PA. The neuropharmacology of tardive dyskinesia, spontaneous dyskinesia, and other dystonias. J Clin Psychopharm 1982;2(5):321–328.

    Article  CAS  Google Scholar 

  41. McMahon WM, Filloux FM, Ashworth JC, Jensen J. Movement disorders in children and adolescents. Neurologic Clin 2002;20(4):1101–1124.

    Article  Google Scholar 

  42. Papapetropoulos S, Mash DC. Psychotic symptoms in Parkinson's disease: from description to etiology. J Neurol 2005;252(7):753–764.

    Article  PubMed  Google Scholar 

  43. Weiner WJ, Rabinstein A, Levin B, Weiner, C, Shulman, L. Cocaine-induced persistent dyskinesias. Neurol 2001;56(7):964–965.

    CAS  Google Scholar 

  44. Abi-Dargham A, Kegeles LS, Zea-Ponce Y, et al. Striatal amphetamine-induced dopamine increase in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123l]lodobenzamide. Biol Psychiatry 2004;55:1001–1006.

    Article  PubMed  CAS  Google Scholar 

  45. Kestler LA, Walker EF, Vega EM. Dopamine receptors in the brains of schizophrenia patients: A meta-analysis of the findings. Behav Pharm 2001;12(5):355–371.

    CAS  Google Scholar 

  46. Swerdlow NR, Koob GF. Dopamine, schizophrenia, mania, and depression: Toward a unified hypothesis of cortico-striato-pallido-thalamic function. Behav Brain Sci 1987;10:197–245.

    Article  Google Scholar 

  47. Gray JA, Veena K, Lawrence N, Young AM. Functions of the dopaminergic innervation of the nucleus accumbens. Psychobiol 1999;27(2):225–235.

    CAS  Google Scholar 

  48. Schulz PM, Schulz C, Goldberg SC, Ettigi P, Resnick RJ, Friedel RO. Diagnoses of the relatives of schizotypal outpatients. J Nerv Ment Dis 1986;174(8):457–463.

    Article  PubMed  CAS  Google Scholar 

  49. Moller P, Husby R. The initial prodrome in schizophrenia: Searching for naturalistic core dimensions of experience and behavior. Schizophr Bull 2000;26(1):217–232.

    PubMed  CAS  Google Scholar 

  50. Lichter DG, Cummings JL. Frontal-Subcortical Circuits in Psychiatric and Neurological Disorders. New York: Guilford Press; 2001.

    Google Scholar 

  51. Ritsner MS, Blumenkrantz H. Predicting domain-specific insight of schizophrenia patients from symptomatology, multiple neurocognitive functions, and personality related traits. Psychiatry Res 2007;149(1–3):59–69.

    Article  PubMed  Google Scholar 

  52. Mednick SA, Machon RA, Huttunen MO, Bonet D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 1988;45:189–192.

    PubMed  CAS  Google Scholar 

  53. Weinberger DR, Berman KF. Speculation on the meaning of cerebral metabolic hypofrontality in schizophrenia. Schizophr Bull 1988;14:157–168.

    PubMed  CAS  Google Scholar 

  54. Cornblatt BA, Walker EF, Green MF, Mittal VA. Schizophrenia: Etiology and Neurocognition. In Millon T, Blaney PH, Davis RD (Eds.), Oxford Textbook of Psychopathology (2nd edition). Oxford University Press: New York; 2008.

    Google Scholar 

  55. Weinstock M. The potential influence of maternal stress hormones on development and mental health of the offspring. Brain Behav Immun 2005;19(4):296–308.

    Article  PubMed  CAS  Google Scholar 

  56. Kiess W, Meidert A, Dressendorfer RA, et al. Salivary cortisol levels throughout childhood and adolescence: Relation with age, pubertal stage and weight. Ped Res 1995;37:502–506.

    Article  CAS  Google Scholar 

  57. Walker EF. Adolescent neurodevelopment and psychopathology. Current Directions in Psychol Sci 2002;11(1):24–28.

    Article  Google Scholar 

  58. Neumann C, Grimes K, Walker E, Baum K. Developmental pathways to schizophrenia: Behavioral subtypes. J Abn Psychol 1995;104(4):558–566.

    Article  CAS  Google Scholar 

  59. Spear LP. Neurodevelopment during adolescence. In: Cicchetti D., Walker E. (Eds.), Neurodevelopmental mechanisms in psychopathology. New York: Cambridge University Press; 2003:62–83.

    Google Scholar 

  60. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res 1982;17(4):319–334.

    Article  PubMed  Google Scholar 

  61. Huttenlocher PR. Synaptic density in human frontal cortex: Developmental changes and effects of again. Brain Res 1979;163(2):195–205.

    Article  PubMed  CAS  Google Scholar 

  62. McGlashan TH, Hoffman RE. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry 2000;57:637–647.

    Article  PubMed  CAS  Google Scholar 

  63. Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 2000;57:65–73.

    Article  PubMed  CAS  Google Scholar 

  64. Mittal VA, Ellman LM, Cannon TD. Gene-environment interaction and covariation in schizophrenia: the role in obstetric complications. Schizophr Bull 2008;34:1083–1094.

    Article  PubMed  Google Scholar 

  65. Cannon TD, Mednick SA. The schizophrenia high-risk project in Copenhagen: Three decades of progress. Act Psychiatr Scand 1993;370(Suppl):33–47.

    Article  CAS  Google Scholar 

  66. Cannon TD, Mednick SA, Parnas J, Schulsinger F, Praestholm J, Vestergaard, A. Developmental brain abnormalities in the offspring of schizophrenic mothers: II. Structural brain characteristics of schizophrenia and schizotypal personality disorder. Arch Gen Psychiatry 1994; 51:955–962.

    PubMed  CAS  Google Scholar 

  67. Siever LJ, Silverman JM, Horvath TB, Howard K, Coccaro E, Keefe RSE. Increased morbid risk for schizophreniarelated disorders in relatives of schizotypal personality disordered patients. Arch Gen Psychiatry 1990;47:634–640.

    PubMed  CAS  Google Scholar 

  68. Fish B. Infant predictors of the longitudinal course of schizophrenic development. Schizophr Bull 1987;13(3):395–409.

    PubMed  CAS  Google Scholar 

  69. Walker EF, Savoie T, Davis D. Neuromotor precursors of schizophrenia. Schizophr Bull 1994;20(3):441–451.

    PubMed  CAS  Google Scholar 

  70. Jones P, Rodgers B, Murray R, Marmot M. Child development risk factors for adult schizoprhiena in the British in 1946 birth cohort. Lancet 1994;344(8934):1398–1402.

    Article  PubMed  CAS  Google Scholar 

  71. Isohanni M, Jones P, Kemppainen L, Croudace T, Isohanni I, Veijola J, Rasanen S, Wahlberg KE, Tienari P, Rantakallio P. Childhood and adolescent predictors of schizophrenia in the Northern Finland 1966 birth cohort— a descriptive life-span model. Eur Arch Psychiatry Clin Neurosci 2003;250(6):311–319.

    Google Scholar 

  72. Schiffman J, Walker E, Ekstrom M, Schulsinger F, Sorensen H, Mednick S. Childhood videotaped social and neuromotor precursors of schizophrenia: A prospective investigation. Am J Psychiatry 2004; 161:2021–2027.

    Article  PubMed  Google Scholar 

  73. Caligiuri MP, Lohr JB. A disturbance in the control of muscle force in neuroleptic-naive schizophrenic patients. Biol Psychiatry 1994;35(2):104–111.

    Article  PubMed  CAS  Google Scholar 

  74. McCreadie RG, Thara R, Kamath S, et al. Abnormal movements in never-medicated Indian patients with schizophrenia. Brit J Psychiatry 1996;168:221–226.

    Article  CAS  Google Scholar 

  75. Gervin M, Browne S, Lane,A, Clarke M, Waddington JL, Larkin C, O'Callaghan E. Spontaneous abnormal involuntary movements in first-episode schizophrenia and schizophreniform disorder: baseline rate in a group of patients from an Irish catchment area. Am J Psychiatry 1998; 155(9):1202–1206.

    PubMed  CAS  Google Scholar 

  76. Turner T. Rich and mad in Victorian England. Psychol Med 1989;19:29–44.

    PubMed  CAS  Google Scholar 

  77. Nagy J, Szatmari P. A chart review of schizotypal personality disorders in children. J Autism Dev Dis 1986;16:351–367.

    Article  CAS  Google Scholar 

  78. Webb CT, Levinson DF. Schizotypal and paranoid personality disorder in the relatives of patients with schizophrenia and affective disorders: A review. Schizophr Res 1993; 11:81–92.

    Article  PubMed  CAS  Google Scholar 

  79. Quinn J, Meagher D, Murphy P, Kinsella A, Mullaney J, Waddington JL. Vulnerability to involuntary movements over a lifetime trajectory of schizophrenia approaches 100%, in association with executive (frontal) dysfunction. Schizophr Res 2001;49(1–2):79–87.

    Article  PubMed  CAS  Google Scholar 

  80. Jeste D, Twamley E, Zorrilla L, Golshan S, Patterson T, Palmer B. Aging and outcome in schizophrenia. Acta Psychiatr Scand 2003;107(5):336–343.

    Article  PubMed  CAS  Google Scholar 

  81. Pearson JS, Kley IB. On the application of genetic expectancies as age specific base rates in the study of human behavior disorders. Psychol Bull 1957;54:406–420.

    Article  PubMed  CAS  Google Scholar 

  82. Mednick SA, Schulsinger F. Some premorbid characteristics related to breakdown in children with schizophrenic mothers. J Psychiatry Res 1968;6:267–291.

    Article  Google Scholar 

  83. Cornblatt, B., Obuchowski, M. Update of high-risk research: 1987–1997. Int Rev Psychiatry 1997;9:437–447.

    Article  Google Scholar 

  84. Larsen TK. McGlashan TH, Moe LC. First-episode schizophrenia: I. Early course parameters. Schizophr Bull 1996; 22(2):241–256.

    PubMed  CAS  Google Scholar 

  85. Cornblatt B, Lencz T, Obuchowski M. The schizophrenia prodrome: treatment and high-risk perspectives. Schizophr Res 2002;54:177–186.

    Article  PubMed  Google Scholar 

  86. Neumann CS, Grimes, K., Walker, E F, Baum K. Developmental pathways to schizophrenia: Behavioral subtypes. J Abn Psychol 1995;104;1–9.

    Article  Google Scholar 

  87. Walker E, Baum K, Diforio D. Developmental changes in the behavioral expression of vulnerability for schizophrenia. In Lenzenweger M., B. Dworkin (Eds.), Experimental psychopathology and the pathogenesis of schizophrenia. Washington, DC: American Psychological Association;1998.

    Google Scholar 

  88. Silverstein ML, Mavrolefteros G, Turnbull A. Premorbid factors in relation to motor, memory, and executive functions deficits in adult schizophrenia. Schizophr Res 2003;61(2–3):271–280.

    Article  PubMed  Google Scholar 

  89. Wolff S. ‘Schizoid’ personality in childhood and adult life I: The vagaries of diagnostic labeling. Brit J Psychiatry 1991;159:615–620.

    Article  CAS  Google Scholar 

  90. Miller TJ, McGlashan TH, Rosen JL, Somjee L, Markovich PJ, Stein K, Woods SW. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry 2002;159(5):863–865.

    Article  PubMed  Google Scholar 

  91. McGorry PD, Bell RC, Dudgeon PL, Jackson HJ. The dimensional structure of first episode psychosis: an exploratory factor analysis. Psychol Med 1998;28(4):935–947.

    Article  PubMed  CAS  Google Scholar 

  92. Sullivan, H. The Onset of Schizophrenia. Am J Psychiatry 1927;84:105–134.

    Google Scholar 

  93. Sanbrook M, Harris A. Evidence for early intervention in first-episode psychosis. Can J Psychiatry 2004;49(4):280–281.

    PubMed  Google Scholar 

  94. Owens DG, Johnstone EC, Crow TJ, Frith CD, Jagoe JR, Kreel L. Lateral ventricular size in schizophrenia: relationship to the disease process and its clinical manifestations. Psychol Med 1985;15(1):27–41.

    Article  PubMed  CAS  Google Scholar 

  95. Szymanski S, Kane JM, Lieberman JA. A selective review of biological markers in schizophrenia. Schizophr Bull 1991;17(1):99–111.

    PubMed  CAS  Google Scholar 

  96. Szymanski S, Lieberman JA, Alvir JM, et al. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. Am J Psychiatry 1995;152(5):698–703.

    PubMed  CAS  Google Scholar 

  97. Dawson ME, Nuechterlein KH, Schell AM, Mintz J. Concurrent and predictive electrodermal correlates of symptomatology in recent-onset schizophrenic patients. J Abn Psychol 1992;101(1):153–164.

    Article  CAS  Google Scholar 

  98. Falloon IR. Early intervention for first episodes of schizophrenia: a preliminary exploration. Psychiatry 1992; 55(1):4–15.

    PubMed  CAS  Google Scholar 

  99. Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, Szymanski SR. Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 1992;149(9):1183–1188.

    PubMed  CAS  Google Scholar 

  100. McGlashan TH. Early detection and intervention in schizophrenia: research. Schizophr Bull 1996;22(2):327–345.

    PubMed  CAS  Google Scholar 

  101. Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, McGorry PD: Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group. Schizophr Res 2003; 60:21–32.

    Article  PubMed  Google Scholar 

  102. Early International Psychosis Association (IEPA). Available at: http://www.iepa.org.au/services/listing.cfm. Accessed June 15, 2008.

  103. First M, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for the DSM-IV Axis I Disorders (SCID-I), Patient Edition. Washington, DC: American Psychiatric Press;1995.

    Google Scholar 

  104. Mittal VA, Tessner K, Delawalla Z, McMillan AK, Trottman H, Walker, EF. Gesture behavior in unmedicated schizotypal adolescents. J Abn Psychology 2006;115(2):351–358.

    Article  Google Scholar 

  105. Grady TA, Broocks A, Canter SK, Pigott TA, Dubbert B, Hill JL, Murphy DL. Biological and behavioral responses to D-amphetamine, alone and in combination with serotonin3 receptor antagonist ondasterone, in healthy volunteers. Psychiatry Res 1996;64:1–10.

    Article  PubMed  CAS  Google Scholar 

  106. Cherland E, Fitzpatrick R. Psychotic side effects of psychostim-ulants: a 5-year review. Can J Psychiatry 1999;44(8): 811–813.

    PubMed  CAS  Google Scholar 

  107. Del Bello MP, Soutullo CA, Hendricks W, Niemeier RT, McElroy SL, Strakowski SM. Prior stimulant treatment in adolescents with bipolar disorder: association with age at onset. Bipol Dis 2001;3(2):53–57.

    Article  Google Scholar 

  108. Caligiuri MP, Lohr JB. A disturbance in the control of muscle force in neuroleptic-naïve schizophrenic patients. Biol Psychiatry 1994;47:434–441.

    Google Scholar 

  109. Walker E, Savoie T, Davis, D. Neuromotor precursors of schizophrenia. Schizophr Bull 1994;20:453–480.

    PubMed  CAS  Google Scholar 

  110. Cardno AG, Rijsdijk FV, Sham PC, Murray RM, McGuffin, P. A twin stud of genetic relationships between psychotic symptoms. Am J Psychiatry 2002;159(4):539–545.

    Article  PubMed  Google Scholar 

  111. Riley B, Kendler KS. Molecular genetic studies of schizophrenia. Eur J Hum Gen 2006;14(6):669–680.

    Article  CAS  Google Scholar 

  112. Fish B. Neurobiologic antecedents of schizophrenia in children: Evidence for an inherited, congenital neurointegrative defect. Arch Gen Psychiatry 1977;34(11):1297–313.

    PubMed  CAS  Google Scholar 

  113. Pogue-Geile MF, Gottesman I. Schizophrenia: Study of a genetically complex phenotype. In: Jones BC, Mormede P (Eds.), Neurobehavioral genetics: Methods and Applications. New York: CRC Press.

    Google Scholar 

  114. Gottesman II, Shields J. Genetic theorizing and Schizophrenia. Br J Psychiatry 1973;122:15–30.

    Article  PubMed  CAS  Google Scholar 

  115. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003;160:636–645.

    Article  PubMed  Google Scholar 

  116. McCreadie, R. G., Thara, R., Srinivasan, T. N., Padmavathi, R. Spontaneous dyskinesia in first-degree relatives of chronically ill, never-treated people with schizophrenia. Brit J Psychiatry 2003;183:45–49.

    Article  Google Scholar 

  117. Egan MF, Hyde TM, Bonomo JB, Mattay VS, et al. Relative risk of neurological signs in siblings of patients with schizophrenia. Am J Psychiatry 2001;158:1827–1834.

    Article  PubMed  CAS  Google Scholar 

  118. Flyckt L, Sydow O, Bjerkenstedt L, Edman G, Gydin E, Wiesel F. Neurological signs and psychomotor performance in patients with schizophrenia their relatives, and healthy controls. Psychiatry Res 1999;86:113–129.

    Article  PubMed  CAS  Google Scholar 

  119. Tarbox SI, Pogue-Geile MF. Spontaneous dyskinesia and familial liability to schizophrenia. Schizophr Res 2006;81(2–3):125–123.

    Article  PubMed  Google Scholar 

  120. Chen R, Chen E, Mak F. Soft neurological signs in schizophrenic patients and their nonpsychotic siblings. J Nerv Ment Disease 2000;188:84–89.

    Article  CAS  Google Scholar 

  121. Kinney DK, Yurgelun-Todd DA, Woods BT. Hard neurologic signs and psychopathology in relatives of schizophrenic patients. Psychiatry Res 1991;39:45–53.

    Article  PubMed  CAS  Google Scholar 

  122. Zai CC, Hwang RW, De Luca V et al. Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients. Intl J Neuropsychopharmacol 2007;10(5):639–651.

    CAS  Google Scholar 

  123. Walker EF, Lewine RR, Neumann C. Childhood behavioral characteristics and adult brain morphology in schizophrenia. Schizophr Res 1996;22(2):93–101.

    Article  PubMed  CAS  Google Scholar 

  124. Smith JF, Chen K, Johnson S, Morrone-Strupinsky J. Network analysis of single-subject fMRI during a finger opposition task. Neuroimage 2006;32(1):325–332.

    Article  PubMed  Google Scholar 

  125. Chan RC, Rao H, Chen EE, Ye B, Zhang C. The neural basis of motor sequencing: an fMRI study of healthy subjects. Neurosci Letters 2006;398(3):189–194.

    Article  CAS  Google Scholar 

  126. Desmurget M, Grea H, Grethe JS, Prablanc C, Alexander GE, Grafton ST. Functional anatomy of nonvisual feedback loops during reaching: a positron emission tomography study. J Neurosci 2001;21(8):2919–2928.

    PubMed  CAS  Google Scholar 

  127. Putzhammer A, Klein HE. Quantitative analysis of motor disturbances in schizophrenic patients. Dialogues Clin Neurosci 2006;8(1):123–130.

    PubMed  Google Scholar 

  128. Fenney A, Jog MS, Duval C. Short-term variability in amplitude and motor topography of whole-body involuntary movements in Parkinson's disease dyskinesias and in Huntington's chorea. Clin Neurol Neurosur 2008;110(2):160–167.

    Article  Google Scholar 

  129. Nikolaus S, Antke C, Kley K, Poeppel TD, Hautzel H, Schmidt D, Muller HW. Investigating the dopaminergic synapse in vivo. I. Molecular imaging studies in humans. Rev Neurosci 2007;18:439–472.

    PubMed  CAS  Google Scholar 

  130. McGorry PD, Yung AR, Phillips LJ, et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 2002;59(10):921–928.

    Article  PubMed  Google Scholar 

  131. Harrigan S, McGorry PD, Krstev H. Does treatment delay in first-episode psychosis really matter? Psychol Med 2003;33:97–110.

    Article  PubMed  CAS  Google Scholar 

  132. Gerbino-Rosen G, Roofeh D, Tompkins DA, et al., Hernatological adverse events in clozapine-treated children and adolescents. J Am Acad Child Adoles Psychiatry 2005;44:1024–1031.

    Article  Google Scholar 

  133. Sporn A, Greenstein D, Gogtay N, Sailer F, Hommer DW, Rawlings R. Childhood-onset schizophrenia: smooth pursuit eye-tracking dysfunction in family members. Schizophr Res 2005;73:243–252.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Postdoctoral Scholar, Department of Psychology, University of California Los Angeles, USA

    Vijay A. Mittal Ph.D.

  2. Samuel Candler Dobbs Professor of Psychology and Neuroscience, Department of Psychology, Emory University, USA

    Elaine F. Walker Ph.D.

Authors
  1. Vijay A. Mittal Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elaine F. Walker Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Israel Institute of Technology, Haifa

    Michael S. Ritsner M.D., Ph.D. (Associate Professor of Psychiatry, the Rappaport Faculty of Medicine Technion) (Associate Professor of Psychiatry, the Rappaport Faculty of Medicine Technion)

  2. Sha'ar Menashe Mental Health Center, Hadera, Israel

    Michael S. Ritsner M.D., Ph.D. (Associate Professor of Psychiatry, the Rappaport Faculty of Medicine Technion) (Associate Professor of Psychiatry, the Rappaport Faculty of Medicine Technion)

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Mittal, V.A., Walker, E.F. (2009). Movement Abnormalities: A Putative Biomarker of Risk for Psychosis. In: Ritsner, M.S. (eds) The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-9464-4_17

Download citation

Publish with us

Policies and ethics

Search

Navigation